200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 162256-50-0

162256-50-0

162256-50-0 | 2(5H)-Furanone, 3-(1,3-benzodioxol-5-yl)-5-hydroxy-5-(4-methoxyphenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-

CAS No: 162256-50-0 Catalog No: AG001SXS MDL No:

Product Description

Catalog Number:
AG001SXS
Chemical Name:
2(5H)-Furanone, 3-(1,3-benzodioxol-5-yl)-5-hydroxy-5-(4-methoxyphenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-
CAS Number:
162256-50-0
Molecular Formula:
C28H26O9
Molecular Weight:
506.5006
IUPAC Name:
3-(1,3-benzodioxol-5-yl)-5-hydroxy-5-(4-methoxyphenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]furan-2-one
InChI:
InChI=1S/C28H26O9/c1-31-19-8-6-18(7-9-19)28(30)20(11-16-12-23(32-2)26(34-4)24(13-16)33-3)25(27(29)37-28)17-5-10-21-22(14-17)36-15-35-21/h5-10,12-14,30H,11,15H2,1-4H3
InChI Key:
PWIPORDFWDZCJG-UHFFFAOYSA-N
SMILES:
COc1ccc(cc1)C1(O)OC(=O)C(=C1Cc1cc(OC)c(c(c1)OC)OC)c1ccc2c(c1)OCO2

Properties

Complexity:
824  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
506.158g/mol
Formal Charge:
0
Heavy Atom Count:
37  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
506.507g/mol
Monoisotopic Mass:
506.158g/mol
Rotatable Bond Count:
8  
Topological Polar Surface Area:
102A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
4  

Literature

Title Journal
Agonist-dependent modulation of arterial endothelinA receptor function. British journal of pharmacology 20120701
Development and evaluation of endothelin-A receptor (radio)ligands for positron emission tomography. Journal of medicinal chemistry 20110224
The separate roles of endothelin receptors participate in remodeling of matrix metalloproteinase and connexin 43 of cardiac fibroblasts in maladaptive response to isoproterenol. European journal of pharmacology 20100525
A fluorescent photoprobe for the imaging of endothelin receptors. Bioconjugate chemistry 20070101
Nitric oxide decreases surfactant protein gene expression in primary cultures of type II pneumocytes. American journal of physiology. Lung cellular and molecular physiology 20050501
Inhibition of in vivo constriction of fetal ductus arteriosus by endothelin receptor blockade in rats. Pediatric research 20030301
Antiarrhythmic effect of endothelin-A receptor antagonist on acute ischemic arrhythmia in isolated rat heart. Acta pharmacologica Sinica 20030101
The endothelin A receptor antagonists PD 156707 (CI-1020) and PD 180988 (CI-1034) reverse the hypoxic pulmonary vasoconstriction in the perinatal lamb. The Journal of pharmacology and experimental therapeutics 20020801
ETA receptor antagonists inhibit intimal smooth muscle cell proliferation in human vessels. Clinical science (London, England : 1979) 20020801
Nitric oxide-endothelin-1 interactions after acute ductal constriction in fetal lambs. American journal of physiology. Heart and circulatory physiology 20020301
ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. American journal of physiology. Lung cellular and molecular physiology 20011101
Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro. British journal of pharmacology 20011101
Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circulation research 20010817
Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors. The Journal of pharmacology and experimental therapeutics 19970201
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722. Journal of medicinal chemistry 19960301

Related Products

© 2019 Angene International Limited. All rights Reserved.